Specifica retweeted
Upcoming free webinar. Registration is open. @SpecificaInc @Andrew0Bradbury webinars-antibodysociety.org…
Specifica retweeted
.@SpecificaInc announced the delivery of an exclusive #antibodylibrary platform to @ucb_news, a #biopharma company focused on the development of medicines for people suffering from immune & central nervous systems disease. More in @medcitynews. bit.ly/2VOVVlE #clientnews
Specifica retweeted
How to identify the right antibodies and validate them appropriately? Find out in this recent manuscript published in mAbs: tandfonline.com/doi/full/10.…
#AbcamReproducibleScience #RecombinantAntibodies #ReproducibleScience
@asolache1 @karolinskainst @TheAbSociety @tandfonline
Specifica retweeted
There’s a growing affinity for recombinant antibodies.
Some, but not all, see polyclonals as relics of an outdated era. Some, but not all, say it’s time for animal-free recombinants. You can read about these views in my story in @naturemethods here: nature.com/articles/s41592-0…
Specifica retweeted
Recombinant antibodies and #knockout cell line-based validation techniques are of increasing importance to the life sciences industry to better support scientific reproducibility. Read more in the latest piece from @metricausa @naturemethods: nature.com/articles/s41592-0…
#CRISPR






